Clindamycin HCL 21462-39-5 Antibiotic
Intlawulo:T/T, L/C
Imvelaphi yeMveliso:eTshayina
Indawo yokuthumela ngenqanawa:Beijing/Shanghai/Hangzhou
Umthamo wemveliso:800kg/ngenyanga
Umyalelo(MOQ):25kg
Ixesha lokukhokhela:Iintsuku zokusebenza ezi-3
Imeko yokugcina:Igcinwe kwindawo epholileyo neyomileyo, ivalwe kwaye igcinwe kude nokukhanya.
Ipakethe imathiriyeli:igubu
Ubungakanani bepakethi:25kg/igubu
Ulwazi ngokhuseleko:Ayizompahla eziyingozi

Intshayelelo
I-Clindamycin sisithinteli-ntsholongwane se-semi-synthetic ene-antibacterial spectrum ebanzi kunye nomsebenzi onamandla wokulwa neebhaktiriya.Inomsebenzi ocacileyo we-antibacterial ngokuchasene ne-Gram-positive bacteria, kwaye inokubulala ngokufanelekileyo i-Staphylococcus, ibhaktiriya ye-anaerobic, i-pneumococcus kunye ne-streptococcus.
Ineempembelelo ezisebenzayo kwii-parasites ze-pathogenic ezifana ne-Pneumocystis, i-Toxoplasma gondii kunye ne-Plasmodium falciparum, kwaye ukusabela okubi kuncinci.
Inkcazo (USP43)
Into | Inkcazo |
Imbonakalo | Imhlophe okanye iphantse ibe mhlophe, umgubo oyikristale Ayinavumba okanye inevumba elifana nele-mercaptan. |
Ukuchongwa | A) IR: Ukuhambelana B) Ixesha lokugcinwa kwencopho enkulu yesisombululo sesampulu sihambelana nesoMgangatho wesisombululo njengoko sifunyenwe kwi-Assay. |
Ubukhazikhazi | Uyahlangabezana neemfuno |
Ph | 3.0-5.5 |
Amanzi | 3.0%-6.0% |
Izinto ezinxulumeneyo | |
Clindamycin B | ≤2.0% |
7-epiclindamycin | ≤4.0% |
Nayiphi enye ikhompawundi enxulumene nomntu | ≤1.0% |
Itotali yazo zonke iikhompawundi ezinxulumeneyo kubandakanya iLincomycin | ≤6.0% |
Izinyibilikisi ezishiyekileyo iAcetone | ≤5000ppm |
Isivavanyi | ≥830μg/mg |